Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens

Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens

Background In vivo targeting of human papillomavirus (HPV) derived antigens to dendritic cells might constitute an efficient immunotherapeutic strategy against cervical cancer. In previous works, we have shown that the extra domain A from murine fibronectin (mEDA) can be used to target antigens to t...

Full description

Bibliographic Details
Main Authors: Pedro J Romero, Sonia Domingos-Pereira, Denise Nardelli-Haefliger, Juan Jose Lasarte, Noelia Casares, Laura Arribillaga, Iciar Echeverria, Viriginia Belsue, Timothy Gomez, Lorea Villanueva, María Josefa Rodriguez, José L Carrascosa, Thomas Zürcher
Format: Article
Language:English
Published: BMJ Publishing Group 2020-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/8/1/e000704.full

Internet

https://jitc.bmj.com/content/8/1/e000704.full

Similar Items